• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN.3; GLYCOSYLATED HEMOGLOBIN ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN.3; GLYCOSYLATED HEMOGLOBIN ASSAY Back to Search Results
Catalog Number 07559674190
Medical Device Problem Code Non Reproducible Results (4029)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/03/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The serial number of the c 513 analyzer used to repeat the samples is (b)(6).The investigation is ongoing.
 
Event or Problem Description
The initial reporter stated they received discrepant results for five patient samples tested with tina-quant hemoglobin a1cdx gen.3.The samples were initially measured on unknown roche analyzers and the samples were repeated on a cobas c513 analyzer commercial system.The samples were being repeated as part of a correlation study.Values from the samples were reported outside of the laboratory.It is unknown which values are considered correct.The first sample initially resulted in an hba1c value of 6.7 % and it repeated as 6.1 %.The second sample initially resulted in an hba1c value of 7.67 % and it repeated as 7.0 %.The third sample initially resulted in an hba1c value of 13.84 % and it repeated as 12.7 %.The fourth sample initially resulted in an hba1c value of 7.47 % on (b)(6) 2025 and it repeated as 6.9 %.The fifth sample initially resulted in an hba1c value of 5.81 % on (b)(6) 2025 and it repeated as 5.2 %.
 
Additional Manufacturer Narrative
The investigation could not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HEMOGLOBIN A1CDX GEN.3
Common Device Name
GLYCOSYLATED HEMOGLOBIN ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22078873
Report Number1823260-2025-01588
Device Sequence Number18242139
Product Code PDJ
UDI-Device Identifier04015630942787
UDI-Public04015630942787
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K160571
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number07559674190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/05/2025
Supplement Date Received by Manufacturer06/11/2025
Initial Report FDA Received Date05/23/2025
Supplement Report FDA Received Date06/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age68 YR
Patient SexFemale
-
-